Research advances toward more effective, long-lasting and side effect-free cancer treatments
The Baylor team is building the case for SRC-3 as a promising therapeutic target for next-generation cancer immunotherapy.
Read More
The Baylor team is building the case for SRC-3 as a promising therapeutic target for next-generation cancer immunotherapy.
Read MoreIn animal models, weaning reshaped the gut microbiome, which in turn ‘trained’ intestinal stem cells to respond better to microbes later in life.
Read MoreHookworm infects an estimated 113 million people globally primarily in sub-Saharan Africa, Southeast Asia and South America. It is a major cause of iron-deficiency anemia in children and pregnant women.
Read MoreTRISH is seeking scientific proposals for secondary analysis of de-identified commercial astronaut health and performance data in the EXPAND Database and Biorepository.
Read MoreThe findings provide a new developmental model of pediatric liver cancer
Read MoreThe findings suggest that modulating the tubulin pool could offer a selective therapeutic strategy.
Read MoreThis work lays the foundation and provides preclinical evidence for a therapeutic approach for Rett syndrome that increases MeCP2 and confers functional improvement.
Read MoreThe findings point out a potential new approach to treatment in which physicians could take actions to prevent resistance, increasing the chances of patient survival.
Read MoreThe Image this month shows a mechanism that mediates the formation of breast cancer cell clusters and promotes cancer metastasis.
Read MoreThis cross-species approach reveals that some paths seem to aggravate the disease while others may protect against it.
Read More